News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
678,713 Results
Type
Article (56594)
Company Profile (235)
Press Release (621884)
Section
Business (198174)
Career Advice (2070)
Deals (32939)
Drug Delivery (71)
Drug Development (76871)
Employer Resources (148)
FDA (15005)
Job Trends (14121)
News (328207)
Policy (26989)
Tag
Academia (2802)
Alliances (50626)
Alzheimer's disease (1254)
Approvals (14993)
Artificial intelligence (155)
Bankruptcy (285)
Best Places to Work (11112)
Biotechnology (157)
Breast cancer (177)
Cancer (1348)
Cardiovascular disease (101)
Career advice (1760)
Cell therapy (268)
Clinical research (60980)
Collaboration (504)
Compensation (175)
COVID-19 (2329)
C-suite (115)
Data (1345)
Diabetes (148)
Diagnostics (5974)
Earnings (77282)
Employer resources (128)
Events (101953)
Executive appointments (399)
FDA (15652)
Funding (429)
Gene therapy (172)
GLP-1 (532)
Government (3156)
Healthcare (17586)
Infectious disease (2415)
Inflammatory bowel disease (107)
Interviews (367)
IPO (14630)
Job creations (3417)
Job search strategy (1533)
Layoffs (385)
Legal (5863)
Lung cancer (215)
Lymphoma (93)
Manufacturing (197)
Medical device (12946)
Medtech (12950)
Mergers & acquisitions (18504)
Metabolic disorders (386)
Neuroscience (1557)
NextGen Class of 2024 (6082)
Non-profit (4372)
Northern California (1546)
Obesity (201)
Opinion (194)
Parkinson's disease (92)
Patents (113)
People (57274)
Phase I (19360)
Phase II (26610)
Phase III (19673)
Pipeline (511)
Postmarket research (2626)
Preclinical (8831)
Radiopharmaceuticals (239)
Rare diseases (243)
Real estate (5982)
Regulatory (19231)
Research institute (2575)
Resumes & cover letters (281)
Southern California (1330)
Startups (3489)
United States (14131)
Vaccines (510)
Weight loss (138)
Date
Today (119)
Last 7 days (583)
Last 30 days (2276)
Last 365 days (33410)
2024 (33257)
2023 (38290)
2022 (49044)
2021 (53060)
2020 (51156)
2019 (44812)
2018 (33891)
2017 (31247)
2016 (31997)
2015 (38041)
2014 (29496)
2013 (25327)
2012 (29683)
2011 (29700)
2010 (29141)
Location
Africa (796)
Arizona (194)
Asia (39808)
Australia (6758)
California (3469)
Canada (1366)
China (304)
Colorado (167)
Connecticut (186)
Europe (91600)
Florida (498)
Georgia (128)
Illinois (391)
Indiana (217)
Maryland (565)
Massachusetts (2679)
Michigan (175)
Minnesota (266)
New Jersey (1051)
New York (1059)
North Carolina (745)
Northern California (1546)
Ohio (137)
Pennsylvania (788)
South America (1127)
Southern California (1330)
Texas (507)
Washington State (396)
678,713 Results for "small business innovation research sbir".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Soaak Technologies Awarded Phase I Small Business Innovation Research (SBIR) Contract from the U.S. Air Force
Soaak Technologies, Inc. has been awarded a Phase I Small Business Innovation Research (SBIR) contract from the U.S. Air Force (USAF) for 2023.
July 20, 2023
·
5 min read
Drug Development
Traverse Biotech Awarded Phase I SBIR Grant by the National Institute of Allergy and Infectious Diseases for Development of Innate Immune Stimulator
Traverse Biotech, Inc. has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH.
May 1, 2024
·
1 min read
Drug Development
Starlight Cardiovascular Awarded $2M NIH SBIR Phase II Grant to Develop Pediatric Cardiology Device
Starlight Cardiovascular, Inc., a company developing pediatric cardiovascular medical devices, announced that it has been awarded a Small Business Innovation Research (SBIR) Phase II grant from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) to advance development of its Pulmonary Flow Restrictor.
May 1, 2024
·
2 min read
Pharm Country
L2P Research Labs Awarded NIH SBIR Grant for Arthritis, Musculoskeletal and Skin Diseases Research
L2P Research, LLC, a leading preclinical CRO, today announced the award of a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH).
October 27, 2023
·
1 min read
Genetown
Fluent BioSciences awarded NIH SBIR grant to commercialize low-cost million-cell transcriptome profiling kits powered by Ultima Genomics sequencing, prototype kits now shipping
Fluent BioSciences is thrilled to announce the award of an NIH Small Business Innovation Research (SBIR) Phase II grant, funded by the National Institute of General Medical Sciences (NIGMS, 2 R44 GM137648).
March 21, 2024
·
3 min read
Sarcomatrix Therapeutics Corp.’s Exclusive Research Partner Strykagen Awarded SBIR Phase 2 Grant from the National Institutes of Health (NIH) to Advance Small Molecules Promoting Muscle Regeneration
Strykagen Corp. announced today that it was awarded a $958,973 (of a total $1,953,245) Small Business Innovative Research (SBIR) grant from the National Institutes of Health (NIH) to conduct Investigational New Drug (IND) enabling studies for S-969, a first-in-class small molecule that may halt or reverse muscle wasting diseases, like muscular dystrophies, cachexia and sarcopenia.
September 20, 2023
·
2 min read
Pharm Country
Xylyx Bio Awarded $2.26M NIH SBIR Grant from National Cancer Institute
Xylyx Bio, Inc. announced that it has been awarded a Small Business Innovation Research Fast-Track grant from the National Cancer Institute of the National Institutes of Health to advance commercial development of its InMatrico® disease modeling and drug testing platform to help scientists discover and test drug candidates for metastatic breast cancer.
June 14, 2024
·
2 min read
Press Releases
Gilead and Terray Therapeutics Announce Multi-Target Research Collaboration to Discover and Develop Novel Small Molecule Therapies
December 17, 2024
·
5 min read
Press Releases
Sinopia Secures Phase II SBIR Grant from the National Institute of Dental and Craniofacial Research for Oral Mucositis
September 12, 2024
·
2 min read
Drug Development
Springbok Analytics Receives $1.7m Phase II SBIR Grant from the NIH to Advance its Rotator Cuff Muscle Analysis Technology
Springbok Analytics (www.springbokanalytics.com ), a life sciences muscle analytics company, announced today that it has received a $1.7 million Phase II Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to develop a commercially viable machine learning algorithm to automatically detect shoulder muscle pathology.
March 5, 2024
·
4 min read
1 of 67,872
Next